{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:18:56Z","timestamp":1773987536391,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>WNT ligands have been critically implicated in many aspects of lung cancer progression. This study explores the impacts of Wnt family member 10A (WNT10A) in progression and immune response in lung adenocarcinoma (LUAD) and investigates the underpinning mechanisms. Expression, prognosis, and immune correlations of WNT10A in LUAD were explored using TCGA-LUAD, GEO datasets, and tissue microarrays. In vitro, WNT10A was knocked down in LUAD cell lines (H441 and H1299), followed by RNA sequencing and functional assays. Tumor-bearing mouse models with WNT10A knockdown were used to assess tumor growth and immune response. The functions of WNT10A on CD8\u2009+\u2009T cell cytotoxicity were further explored through co-culture experiments and flow cytometry. FRAT1 overexpression, Wnt activators (BML-284), and CXCL12 manipulations were employed to verify mechanistic links. High WNT10A expression showed a trend toward poor overall survival, reduced CD8\u2009+\u2009T cell infiltration, and unfavorable prognosis in LUAD patients. WNT10A loss in LUAD cells reduced growth, mobility, and inhibited Wnt signaling. In vivo, WNT10A loss prolonged animal survival in immunocompetent mice, reduced tumorigenic activity of mouse 3LL cells, and enhanced CD8\u2009+\u2009T cell activity and tumor cell apoptosis. Mechanistically, WNT10A promoted FRAT1-mediated suppression of GSK3\u03b2, facilitating CTNNB1 activation and CXCL12 expression, which restricted CD8\u2009+\u2009T cell function. WNT10A silencing synergized with anti-PD-1, reducing tumor burden and boosting CD8\u2009+\u2009T cell infiltration\/function. Generally, WNT10A promotes LUAD progression and CD8\u2009+\u2009T cell dysfunction through FRAT1-mediated Wnt signaling and CXCL12 activation. Focusing on WNT10A could offer a compelling approach to boosting T cell-driven anti-tumor responses for the treatment of LUAD.<\/jats:p>","DOI":"10.1093\/ajrcmb\/aanag053","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:31:31Z","timestamp":1773981091000},"source":"Crossref","is-referenced-by-count":0,"title":["Unique Pathways that drive CD8+ T cell dysfunction and immune evasion in lung adenocarcinoma"],"prefix":"10.1093","author":[{"given":"Jinjin","family":"Chen","sequence":"first","affiliation":[{"name":"The Yancheng Clinical College of Xuzhou Medical University Oncology Department, The First People\u2019s Hospital of Yancheng City, , Yancheng, 224005, Jiangsu, P.R.","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Wen","sequence":"additional","affiliation":[{"name":"The Yancheng Clinical College of Xuzhou Medical University Department of General Practice, The First People\u2019s Hospital of Yancheng City, , Yancheng, 224005, Jiangsu, P.R.","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwei","family":"Chen","sequence":"additional","affiliation":[{"name":"The Yancheng Clinical College of Xuzhou Medical University Department of Thoracic Surgery, The First People\u2019s Hospital of Yancheng City, , Yancheng, 224005, Jiangsu, P.R.","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[{"name":"The Yancheng Clinical College of Xuzhou Medical University Department of Thoracic Surgery, The First People\u2019s Hospital of Yancheng City, , Yancheng, 224005, Jiangsu, P.R.","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[{"name":"The Yancheng Clinical College of Xuzhou Medical University Department of Thoracic Surgery, The First People\u2019s Hospital of Yancheng City, , Yancheng, 224005, Jiangsu, P.R.","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhao","family":"Sun","sequence":"additional","affiliation":[{"name":"The Yancheng Clinical College of Xuzhou Medical University Department of Thoracic Surgery, The First People\u2019s Hospital of Yancheng City, , Yancheng, 224005, Jiangsu, P.R.","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,19]]},"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article-pdf\/doi\/10.1093\/ajrcmb\/aanag053\/67420765\/aanag053.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article-pdf\/doi\/10.1093\/ajrcmb\/aanag053\/67420765\/aanag053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:31:35Z","timestamp":1773981095000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article\/doi\/10.1093\/ajrcmb\/aanag053\/8529351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/ajrcmb\/aanag053","relation":{},"ISSN":["1535-4989"],"issn-type":[{"value":"1535-4989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"aanag053"}}